Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
In response to myocardial infarction (MI), the wound healing response of the left ventricle (LV) consists of overlapping inflammatory, proliferative, and maturation phases; and the cardiac fibroblast is a key cell type involved in each phase. It has recently been appreciated that early post-MI, fibroblasts transform to a pro-inflammatory phenotype and secrete cytokines and chemokines as well as matrix metalloproteinases. Later post-MI, fibroblasts are activated to anti-inflammatory and pro-reparative phenotypes and generate anti-inflammatory and pro-angiogenic factors and extracellular matrix components that form the infarct scar. Additional studies are needed to systematically examine how fibroblast activation shifts over the time frame of MI response and how modulation at different activation stages could alter wound healing and LV remodeling in distinct ways. This review will summarize current fibroblast knowledge as a foundation to discuss existing knowledge gaps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596 · cited 1×
“The presence of abundant ECM may also decrease oxygen and nutrient availability to the myocardium, amplifying the pathological remodeling response [2].”
BackgroundRevisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 2×
“A transgenic collagen1α1-green fluorescent protein reporter line has been developed to track collagen 1-positive cells [15, 20].”
BackgroundGenetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 2×
“colleagues recently reported that the periostin genetic locus (PostnMCM) can be used to identify almost all subtypes of cardiac myofibroblasts [22].”
BackgroundSerini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847
A myocardial lineage derives from Tbx18 epicardial cells
Cai, C.-L., Martin, J. C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., et al. (2008) · Nature · doi:10.1038/nature06969 · Cited by 784
Myocardial remodeling after infarction: the role of myofibroblasts
van den Borne, S. W. M., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., & Narula, J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.199 · Cited by 739
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 719 · cited 1×
“MCP-1 deficiency results in attenuated myofibroblast infiltration in the infarct [53, 54].”
BackgroundIdentification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699 · cited 1×
“Despite its name, FSP-1 is widely expressed in fibroblasts, leukocytes, and a number of cancer cell types [26].”
BackgroundResident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630 · cited 2×
“A transgenic collagen1α1-green fluorescent protein reporter line has been developed to track collagen 1-positive cells [15, 20].”
BackgroundResultMikawa, T., & Gourdie, R. G. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0068 · Cited by 620 · cited 4×
“During development, the majority of cardiac fibroblasts originate from epicardial cells that undergo an epithelial-to-mesenchymal transition (EMT) [3, 4].”
BackgroundInfluentialThe origin of fibroblasts and mechanism of cardiac fibrosis
Krenning, G., Zeisberg, E. M., & Kalluri, R. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22322 · Cited by 601 · cited 1×
“In spite of recent progress in the identification of multiple cardiac fibroblast markers, specificity still remains a key challenge [18, 19].”
BackgroundRedox-mediated activation of latent transforming growth factor-beta 1
Barcellos-Hoff, M. H. (1996) · Molecular Endocrinology · doi:10.1210/me.10.9.1077 · Cited by 585
Dobaczewski, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.015 · Cited by 548
Fibroblasts in myocardial infarction: A role in inflammation and repair
Shinde, A. V., & Frangogiannis, N. G. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.015 · Cited by 522
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors
Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J.-H., Butterfield, C., Lin, R.-Z., Melero-Martin, J. M., Dolmatova, E., Duffy, H. S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45529 · Cited by 517 · cited 2×
“Importantly, these EPDCs have been shown to reduce infarct size, facilitate angiogenesis, and preserve cardiac physiology by secreting paracrine factors [10].”
BackgroundAcharya, A., Baek, S. T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C. Y., Banfi, S., Sauer, M. F., Olsen, G. S., Duffield, J. S., et al. (2012) · Development · doi:10.1242/dev.079970 · Cited by 498 · cited 1×
“Acharya and colleagues have shown that Tcf21−/− hearts lack cardiac fibroblasts, indicating that Tcf21 is required for cardiac fibroblast cell fate determination [21].”
BackgroundRegulation of collagen degradation in the rat myocardium after infarction
CLEUTJENS, J., KANDALA, J., GUARDA, E., GUNTAKA, R., & WEBER, K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(05)82390-9 · Cited by 479 · cited 1×
“In this phase, inflammation has receded, and myofibroblasts are the main players [66, 67].”
BackgroundTeekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M., Konno, T., Gorham, J. M., Wolf, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42028 · Cited by 448
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385 · cited 2×
“TGF-β1 and fibroblast growth factor) can stimulate fibroblast migration into the infarct [45, 51, 55], the direct effects of these pro-fibrotic factors on scar formation after MI remain poorly defined.”
BackgroundThe alpha-smooth muscle actin-positive cells in healing human myocardial scars.
WILLEMS, I. E. M. G., Havenith, M. G., Mey, J. G. R. D., & Daemen, M. J. A. P. (1994) · PubMed Central · Cited by 385
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382 · cited 1×
“In this phase, inflammation has receded, and myofibroblasts are the main players [66, 67].”
BackgroundSensing extracellular matrix: An update on discoidin domain receptor function
Vogel, W. F., Abdulhussein, R., & Ford, C. E. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.012 · Cited by 368 · cited 1×
“In addition to fibroblasts, DDR2 is also expressed in VSMCs and activated endothelial cells [25].”
BackgroundSmith, C. L., Baek, S. T., Sung, C. Y., & Tallquist, M. D. (2011) · Circulation Research · doi:10.1161/circresaha.110.235531 · Cited by 339 · cited 1×
“PDGFR α signaling is required for epicardial EMT and the development of EPDCs and resident fibroblasts [20, 31].”
BackgroundAli, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Müller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 309 · cited 3×
“A minority of fibroblasts derive from endothelial cells or paired box 3-expressing cells [5].”
BackgroundInfluentialAisagbonhi, O., Rai, M., Ryzhov, S., Atria, N., Feoktistov, I., & Hatzopoulos, A. K. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006510 · Cited by 302 · cited 1×
“EndMT-derived fibroblasts have been reported to account for <1% of the total number of cells in the unstressed heart, but this number expands to about 25% in the ischemic heart [12].”
BackgroundFrangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289 · cited 1×
“MCP-1 deficiency results in attenuated myofibroblast infiltration in the infarct [53, 54].”
BackgroundFibroblasts in post-infarction inflammation and cardiac repair
Chen, W., & Frangogiannis, N. G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.023 · Cited by 270
Harada, M., Luo, X., Qi, X. Y., Tadevosyan, A., Maguy, A., Ordog, B., Ledoux, J., Kato, T., Naud, P., Voigt, N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.121830 · Cited by 268
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts
Booz, G. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(96)88507-5 · Cited by 237
Mechanical control of cardiac myofibroblasts
van Putten, S., Shafieyan, Y., & Hinz, B. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.025 · Cited by 234
Frangogiannis, N. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00158-9 · Cited by 230
Heart Failure After Myocardial Infarction: Clinical Implications and Treatment
Minicucci, M. F., Azevedo, P. S., Polegato, B. F., Paiva, S. A. R., & Zornoff, L. A. M. (2011) · Clinical Cardiology · doi:10.1002/clc.20922 · Cited by 220 · cited 1×
“Though not primarily targeting fibrosis, current therapeutic agents for patients with MI, including angiotensin converting enzyme inhibitors, angiotensin AT1 receptor blockers, aldosterone antagonists, β blockers, and statins have secondary anti-fibrotic effects that are beneficial to outcomes [82].”
BackgroundTurner, N. A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.002 · Cited by 216
TURNER, N., MUGHAL, R., WARBURTON, P., OREGAN, D., BALL, S., & PORTER, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.003 · Cited by 215
Palmer, J. N., Hartogensis, W. E., Patten, M., Fortuin, F. D., & Long, C. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117956 · Cited by 203
van Amerongen, M., Bou‐Gharios, G., Popa, E., van Ark, J., Petersen, A., van Dam, G., van Luyn, M., & Harmsen, M. (2008) · The Journal of Pathology · doi:10.1002/path.2281 · Cited by 193 · cited 2×
“These myofibroblasts derived from bone marrow produce collagen and are involved in scar formation post-MI [9].”
BackgroundRettig, W. J., Garin‐Chesa, P., Healey, J. H., Su, S. L., Ozer, H. L., Schwab, M. G., Albino, A. P., & Old, L. J. (1993) · PubMed · Cited by 188
Hwang, M., Matsumori, A., Furukawa, Y., Ono, K., Okada, M., Iwasaki, A., Hara, M., Miyamoto, T., Touma, M., & Sasayama, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01591-1 · Cited by 175
Function and fate of myofibroblasts after myocardial infarction
Turner, N. A., & Porter, K. E. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-5 · Cited by 171
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling
Ma, Y., de Castro Brás, L. E., Toba, H., Iyer, R. P., Hall, M. E., Winniford, M. D., Lange, R. A., Tyagi, S. C., & Lindsey, M. L. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1463-9 · Cited by 162 · cited 3×
“multiple origins, including proliferation of resident cardiac fibroblasts, bone marrow-derived progenitors, epicardial cells, and endothelial cells [6, 7].”
BackgroundSelf-citationRuiz‐Villalba, A., Simón, A. M., Pogontke, C., Castillo, M. I., Abizanda, G., Pelacho, B., Sánchez‐Domínguez, R., Segovia, J. C., Prósper, F., & Pérez-Pomares, J. M. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.520 · Cited by 159 · cited 1×
“While epicardial cells are quiescent in the normal adult heart, MI can induce epicardial cell proliferation and stimulate their activation to form epicardium-derived cells (EPDCs) [10, 11].”
BackgroundLindsey, M. L., Iyer, R. P., Zamilpa, R., Yabluchanskiy, A., DeLeon-Pennell, K. Y., Hall, M. E., Kaplan, A., Zouein, F. A., Bratton, D., Flynn, E. R., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.035 · Cited by 159
Self-citationMouse strain determines the outcome of wound healing after myocardial infarction
van den Borne, S. W. M., van de Schans, V. A. M., Strzelecka, A. E., Vervoort-Peters, H. T. M., Lijnen, P. M., Cleutjens, J. P. M., Smits, J. F. M., Daemen, M. J. A. P., Janssen, B. J. A., & Blankesteijn, W. M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp207 · Cited by 154
Peng, J., Gurantz, D., Tran, V., Cowling, R. T., & Greenberg, B. (2002) · Circulation Research · doi:10.1161/01.res.0000047090.08299.d5 · Cited by 154
van Nieuwenhoven, F. A., & Turner, N. A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.07.003 · Cited by 143
IL-1β stimulates rat cardiac fibroblast migration via MAP kinase pathways
Mitchell, M. D., Laird, R. E., Brown, R. D., & Long, C. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00881.2005 · Cited by 141
Mechanical Tension and Integrin α2β1 Regulate Fibroblast Functions
Eckes, B., Zweers, M. C., Zhang, Z., Hallinger, R., Mauch, C., Aumailley, M., & Krieg, T. M. (2006) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsymp.5650003 · Cited by 139
Braitsch, C. M., Kanisicak, O., van Berlo, J. H., Molkentin, J. D., & Yutzey, K. E. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.005 · Cited by 132 · cited 1×
“Tcf21, Wt1, and Tb×18) and the localization of cardiac fibrosis [17].”
BackgroundAltered fibroblast function following myocardial infarction
Squires, C. E., ESCOBAR, G., PAYNE, J., LEONARDI, R., Goshorn, D. K., Sheats, N. J., Mains, I. M., Mingoia, J. T., Flack, E. C., & Lindsey, M. L. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.008 · Cited by 131 · cited 1×
“Cardiac fibroblast activation has been defined mostly in terms of in vitro single stimulus responses; there is a need to understand how fibroblasts respond to mixed stimuli [7, 23, 32].”
BackgroundSelf-citationOrigin, development, and differentiation of cardiac fibroblasts
Lajiness, J. D., & Conway, S. J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.003 · Cited by 130 · cited 1×
“multiple origins, including proliferation of resident cardiac fibroblasts, bone marrow-derived progenitors, epicardial cells, and endothelial cells [6, 7].”
BackgroundTranscriptional control of cardiac fibroblast plasticity
Lighthouse, J. K., & Small, E. M. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.016 · Cited by 129 · cited 1×
“Following polymerization of filamentous-actin, MRTFs bind to transcription factor serum response factor (SRF) and induce α-SMA expression in vascular smooth muscle cells [62].”
BackgroundInterleukin-1α stimulates proinflammatory cytokine expression in human cardiac myofibroblasts
Turner, N. A., Das, A., Warburton, P., O'Regan, D. J., Ball, S. G., & Porter, K. E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2009 · Cited by 125
Extracellular matrix roles during cardiac repair
Saux, C. J., Zhang, J., & Lindsey, M. L. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.07.010 · Cited by 119 · cited 1×
“Proliferative Phase—The post-MI proliferative phase is characterized by the formation of granulation tissue composed of macrophages, myofibroblasts, new blood vessels, and newly synthesized ECM [50].”
BackgroundSelf-citationThe Extracellular Matrix Modulates Fibroblast Phenotype and Function in the Infarcted Myocardium
Dobaczewski, M. P., de Haan, J. J., & Frangogiannis, N. G. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9406-3 · Cited by 116
Hydrogen Peroxide Is a Novel Inducer of Connective Tissue Growth Factor
Park, S.-K., Kim, J., Seomun, Y., Choi, J., Kim, D.-H., Han, I., Lee, E. H., Chung, S.-K., & Joo, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5058 · Cited by 113
Susceptibility to Arrhythmia in the Infarcted Heart Depends on Myofibroblast Density
McDowell, K. S., Arevalo, H., Maleckar, M. M., & Trayanova, N. A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.08.009 · Cited by 108
Yano, T., Miura, T., Ikeda, Y., Matsuda, E., Saito, K., Miki, T., Kobayashi, H., Nishino, Y., Ohtani, S., & Shimamoto, K. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.05.004 · Cited by 103 · cited 1×
“Although proliferation of the resident cardiac fibroblast is considered as the main source of myofibroblasts in the infarct, other sources contribute [8].”
BackgroundXie, Y., Garfinkel, A., Weiss, J. N., & Qu, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00341.2009 · Cited by 101
Zeigler, A. C., Richardson, W. J., Holmes, J. W., & Saucerman, J. J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.03.008 · Cited by 98
Lijnen, P. J., Papparella, I., Petrov, V. V., Semplicini, A., & Fagard, R. H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217860.04994.54 · Cited by 92
O’Connor, J. W., & Gomez, E. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083188 · Cited by 92
Myofibroblasts in the Infarct Area: Concepts and Challenges
Daskalopoulos, E. P., Janssen, B. J., & Blankesteijn, W. M. (2012) · Microscopy and Microanalysis · doi:10.1017/s143192761101227x · Cited by 90
A Model of Electrical Conduction in Cardiac Tissue Including Fibroblasts
Sachse, F. B., Moreno, A. P., Seemann, G., & Abildskov, J. A. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9667-4 · Cited by 89
Tumor Necrosis Factor- α at Acute Myocardial Infarction in Rats andÈEffects on Cardiac Fibroblasts
Jacobs, M., Staufenberger, S., Gergs, U., Meuter, K., Brandstätter, K., Hafner, M., Ertl, G., & Schorb, W. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1007 · Cited by 89
Extracellular Matrix and Fibroblast Communication Following Myocardial Infarction
Ma, Y., Halade, G. V., & Lindsey, M. L. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9398-z · Cited by 89 · cited 2×
“The most commonly used marker to identify activated myofibroblasts is α-SMA, which is also highly abundant in vascular smooth muscle cells (VSMCs) and pericytes [23].”
BackgroundSelf-citationIn Fibroblasts Vegf-D Expression Is Induced by Cell-Cell Contact Mediated by Cadherin-11
Orlandini, M., & Oliviero, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009573200 · Cited by 86
MKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells
Elberg, G., Chen, L., Elberg, D., Chan, M. D., Logan, C. J., & Turman, M. A. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00142.2007 · Cited by 75
Regulation of vimentin expression in cultured human mammary epithelial cells
Mark, C., van Deurs, B., & Petersen, O. W. (1990) · Differentiation · doi:10.1111/j.1432-0436.1990.tb00441.x · Cited by 71
Myofibroblasts and inflammatory cells as players of cardiac fibrosis
Kurose, H., & Mangmool, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0809-6 · Cited by 68 · cited 1×
“In spite of recent progress in the identification of multiple cardiac fibroblast markers, specificity still remains a key challenge [18, 19].”
BackgroundSaliba, Y., Karam, R., Smayra, V., Aftimos, G., Abramowitz, J., Birnbaumer, L., & Farès, N. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010065 · Cited by 67 · cited 1×
“TRPC3 triggers myofibroblast differentiation in atrial and renal fibroblasts through a nuclear factor of activated T cells- and extracellular signal-regulated kinases 1/2-dependent manner [60, 61].”
BackgroundHarnessing the Heart of Big Data
Scruggs, S. B., Watson, K., Su, A. I., Hermjakob, H., Yates, J. R., Lindsey, M. L., & Ping, P. (2015) · Circulation Research · doi:10.1161/circresaha.115.306013 · Cited by 66 · cited 1×
“Using big data approaches will help to harness this attempt by exploring which of the many variables that can be measured need to be included to define the phenotype [72].”
MethodSelf-citationComputational modeling of cardiac fibroblasts and fibrosis
Zeigler, A. C., Richardson, W. J., Holmes, J. W., & Saucerman, J. J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.020 · Cited by 63 · cited 1×
“The Saucerman lab has developed cellular level models of fibroblast activation and kinetics that have application to post-MI cardiac remodeling [78, 79].”
MethodActivation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction
Fligny, C., & Duffield, J. S. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835b656b · Cited by 57 · cited 1×
“Fibrocytes, pericytes and monocyte precursors are reported to be potential sources of fibroblasts [7, 13, 14].”
BackgroundConstruction of a large scale integrated map of macrophage pathogen recognition and effector systems
Raza, S., McDerment, N. A., Lacaze, P. A., Robertson, K. A., Watterson, S., Chen, Y., Chisholm, M., Eleftheriadis, G., Monk, S. L., O'Sullivan, M., et al. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-63 · Cited by 45 · cited 1×
“Logic-based diagrams of signaling pathways can be used to frame cell responses at different activation stages with flexibility to allow orchestration across inputs [80].”
Backgroundvan Nieuwenhoven, F. A., Hemmings, K. E., Porter, K. E., & Turner, N. A. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.03.008 · Cited by 45
Trial, J., Cieslik, K. A., Haudek, S. B., Duerrschmid, C., & Entman, M. L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00287 · Cited by 38 · cited 1×
“Fibrocytes, pericytes and monocyte precursors are reported to be potential sources of fibroblasts [7, 13, 14].”
BackgroundThe Janus face of myofibroblasts in the remodeling heart
Hermans, K. C. M., Daskalopoulos, E. P., & Blankesteijn, W. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.017 · Cited by 37 · cited 1×
“It has been shown that myofibroblasts can remain active in the infarct region, even up to 18 years post-MI in humans [70, 71].”
BackgroundRole of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype
Roche, P. L., Nagalingam, R. S., Bagchi, R. A., Aroutiounova, N., Belisle, B. M. J., Wigle, J. T., & Czubryt, M. P. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00333.2015 · Cited by 37
Self-citationRole of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration
Freed, D. H., Chilton, L., Li, Y., Dangerfield, A. L., Raizman, J. E., Rattan, S. G., Visen, N. S., Hryshko, L. V., & Dixon, I. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01041.2010 · Cited by 30 · cited 1×
“TGF-β1 and fibroblast growth factor) can stimulate fibroblast migration into the infarct [45, 51, 55], the direct effects of these pro-fibrotic factors on scar formation after MI remain poorly defined.”
BackgroundFibroblast proliferation alters cardiac excitation conduction and contraction: a computational study
Zhan, H., Xia, L., Shou, G., Zang, Y., Liu, F., & Crozier, . (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300156 · Cited by 19
CARFMAP: A Curated Pathway Map of Cardiac Fibroblasts
Nim, H. T., Furtado, M. B., Costa, M. W., Kitano, H., Rosenthal, N. A., & Boyd, S. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143274 · Cited by 12 · cited 2×
“From expression profiles of mouse cardiac and tail fibroblasts, the authors have applied CARFMAP to characterize cardiac fibroblast pathways [77].”
Background
Cited by
Guidelines for experimental models of myocardial ischemia and infarction
Lindsey, M. L., Bolli, R., Canty, J. M., Du, X.-J., Frangogiannis, N. G., Frantz, S., Gourdie, R. G., Holmes, J. W., Jones, S. P., Kloner, R. A., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2017 · Cited by 526
Self-citationMa, Y., Mouton, A. J., & Lindsey, M. L. (2018) · Translational Research · doi:10.1016/j.trsl.2017.10.001 · Cited by 405
“Conversion of these initial models into logic-based distinct equations will provide a window for simulations with other key players that may be identified to build on the existing framework.(142) The in silico integration of complex data sets can help define key trigger point responses, combined with bioinformatics an…”
BackgroundSelf-citationComparative regenerative mechanisms across different mammalian tissues
Iismaa, S. E., Kaidonis, X., Nicks, A. M., Bogush, N., Kikuchi, K., Naqvi, N., Harvey, R. P., Husain, A., & Graham, R. M. (2018) · npj Regenerative Medicine · doi:10.1038/s41536-018-0044-5 · Cited by 253
Metadata
- Authors
- Ma, Y., Iyer, R. P., Jung, M., Czubryt, M. P., & Lindsey, M. L.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 38
- Issue
- 5
- Pages
- 448-458
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2598923058
- Cited by
- 202
- References
- 83
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.